NCT04073979View on ClinicalTrials.gov

MATTERS II - Mistral Percutaneous Tricuspid Valve Repair FIM Study

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

April 2, 2019

Primary Completion Date

January 31, 2021

Study Completion Date

December 31, 2022

Conditions
Tricuspid Valve Regurgitation
Interventions
DEVICE

Mistral implantation

Mistral implant is implanted in the Tricuspid valve

Trial Locations (4)

22087

Marienkrankenhaus, Hamburg

22527

Medizinisches Versorgungszentrum Albertinen (MVZ), Hamburg

80539

LMU [Ludwig-Maximilians-Universität München], Munich

Unknown

Cardiovascular Center (CVC), Frankfurt

Sponsors

Lead Sponsor

Mitralix
All Listed Sponsors
lead

Mitralix

INDUSTRY